Credit Suisse Upgrades Edwards Lifesciences (EW) to Outperform
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.60 -1.04%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Credit Suisse upgraded Edwards Lifesciences (NYSE: EW) from Neutral to Outperform with a price target of $81.00.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $66.09 yesterday.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $66.09 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- UBS Upgrades Pagegroup Plc. (PAGE:LN) (MPGPY) to Buy
- JPMorgan Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
Create E-mail Alert Related Categories
UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
